[
    {
        "title": "Kiora Pharmaceuticals Completes Last Patient, Last Visit in Phase 1B Trial of KIO-301 in Patients with Retinitis Pigmentosa - Yahoo Finance",
        "description": "Kiora Pharmaceuticals Completes Last Patient, Last Visit in Phase 1B Trial of KIO-301 in Patients with Retinitis Pigmentosa  Yahoo Finance",
        "published date": "Mon, 18 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9raW9yYS1waGFybWFjZXV0aWNhbHMtY29tcGxldGVzLWxhc3QtcGF0aWVudC0xMTAwMDAzMDYuaHRtbNIBYmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2tpb3JhLXBoYXJtYWNldXRpY2Fscy1jb21wbGV0ZXMtbGFzdC1wYXRpZW50LTExMDAwMDMwNi5odG1s?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]